Monday, 5 September 2011
Low dose naltrexone affects cell proliferation
Low-dose naltrexone targets the opioid growth factor–opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model. Experimental Biology & Medicine. September 2011.
Download the full-text here.
Read more about this study here.
Read a Questioning Answers post on naltrexone and autism here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.